Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzhou Sinoway Pharmaceutical Technology is a specialized biotechnology firm focused on the R&D and manufacturing of advanced pharmaceutical intermediates and active pharmaceutical ingredients (APIs). Based in the Suzhou Industrial Park, the company operates as a CRO and CDMO, providing custom synthesis, process development, and scale-up services to the global life sciences industry. Their technical expertise is particularly strong in complex small molecule synthesis and peptide chemistry, supporting therapeutic areas such as oncology and cardiovascular health. Sinoway serves as a critical partner for pharmaceutical companies seeking high-quality chemical building blocks and regulatory-compliant manufacturing solutions. The company emphasizes quality management systems and maintains facilities capable of supporting projects from early-stage research through to commercial production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Suzhou Sinoway Pharmaceutical Technology.